Are there weight loss trials that pay?

Weight loss trials that pay can be found through ClinicalTrials.gov, university registries, and local research centers, but listings do not guarantee current recruitment or compensation. Check the study record, then ask the site about eligibility, visit burden, payment, travel costs, risks, and withdrawal terms before deciding whether to enroll.
Are there any paid clinical trials for weight loss near me?
Yes, some weight-loss clinical studies may compensate participants, but payment and local availability must be confirmed with the study site. ClinicalTrials.gov is a searchable registry: use its search tools to look for weight-management studies near your location, then contact the research team listed on a relevant record.
Use a short verification sequence. Search by condition or treatment and location. Read each record for recruitment status, study design, eligibility, and site contact details. Then ask the site whether it is still enrolling and whether participants receive compensation. A registry listing is a starting point, not a promise of an open place or a paid spot.
University research registries and nearby academic medical centers can provide another route. Search their research pages for obesity, weight management, or metabolic studies, then verify details directly. The status of a study and its availability can change between a registry update and your call.

How much do weight loss clinical trials pay, and what affects the amount?
There is no standard payment amount for weight-loss trials in the provided government guidance or study records. Compensation depends on the protocol and its time and procedure demands. A headline maximum alone does not show what a participant earns for each completed visit or whether travel costs are included.
Compare the terms in separate categories. Ask for payment per visit or milestone, the total possible payment, the schedule for receiving it, and whether travel or lodging is reimbursed separately. Then compare those terms with the number of visits, overall duration, screening steps, and any overnight stays. A larger advertised maximum can come with a longer commitment; the record must be checked against the site's current details.
For example, ClinicalTrials.gov lists retatrutide study NCT07232719 as an approximately 65-week commitment with about 18 visits. Its record does not state participant compensation. The study is listed as active but not recruiting, and both status and availability can change. Contact the site to ask whether recruitment has opened and what payment terms apply.
OHRP guidance says reasonable travel and lodging reimbursement is distinct from compensation for participating. Ask which expenses qualify, whether receipts are needed, and whether reimbursement arrives separately. The study team's written consent materials should describe the payment arrangement and conditions for partial or no payment if participation ends early.
What company pays you to lose weight, and how can I verify a study is legitimate?
There is no single company that pays everyone to lose weight; payment is set by the study protocol and handled through the research site. A sponsor may fund a trial, while a university, hospital, or research center conducts it. Verify the specific study and site rather than relying on a broad claim that a company pays participants.
ClinicalTrials.gov records identify a study's sponsor, locations, status, and contact information. Check that the study details match what you were told, then use the listed contact to confirm recruitment and payment. The registry explains that records help people find studies and contact research teams about participation requirements.
Ask the site to explain the study purpose, procedures, possible risks, and whether treatment is experimental. NCT07232719, for instance, describes a randomized, double-blind comparison of retatrutide with placebo. Participants may not know which they receive during the trial. That design is a reason to ask about placebo assignment, not evidence that every weight-loss study uses placebo.
Before signing, review the consent form. HHS's Office for Human Research Protections says consent for covered research must explain purpose and duration, procedures, foreseeable risks and potential benefits, confidentiality, and whom to contact. It must also state that participation is voluntary and that participants can discontinue without penalty or loss of benefits to which they are otherwise entitled.
How do I check eligibility for a paid obesity or GLP-1 study?
Check the record's inclusion and exclusion criteria, then ask the study team to assess your individual eligibility. Common screening factors include age, body mass index (BMI), weight-related health conditions, current or recent medications, medical history, and location. Meeting a listed threshold does not guarantee acceptance.
The retatrutide study NCT07232719 lists adults aged 18 or older with BMI of at least 30, or at least 27 with a qualifying weight-related condition, as potential candidates; it also lists a previous unsuccessful diet attempt. The record lists exclusions including type 1 or type 2 diabetes, recent use of weight-loss drugs, and certain personal or family medical histories. The study team determines whether any person's circumstances meet the full criteria.
A separate record, NCT07467447, lists a recruiting study with a site in Shenzhen, China. Its criteria include BMI ranges and detailed medical and medication exclusions. The record describes treatment followed by a safety follow-up and does not list compensation. Its location and recruitment status should be checked with the site before applying.
Prepare accurate information about your health conditions and medicines for the screening conversation. Ask whether the study requires a local visit, how screening works, and what happens if you do not qualify. The research team—not an online checklist—makes the eligibility decision.
Frequently Asked Questions
How do I find out whether a retatrutide trial is recruiting and how can I apply?
Search the study name or condition on ClinicalTrials.gov and check the record's recruitment status and locations. The retatrutide record NCT07467447 lists a recruiting site in Shenzhen, China, while NCT07232719 is listed as active but not recruiting; status can change. Contact the listed site to confirm availability, eligibility, and how to apply.
Do trials cover study medication, medical visits, travel, or lodging?
Coverage depends on the study and should be confirmed with the research site. Ask which study-related medication and medical visits are provided, what expenses remain yours, and whether travel or lodging is reimbursed; reimbursement is separate from payment for participation.
Can I leave a weight-loss trial early and still be paid for visits I completed?
Participation in covered research is voluntary, and informed consent must explain that participants can discontinue without penalty or loss of benefits to which they are otherwise entitled. Payment terms can vary, so ask whether completed visits are paid if you withdraw or are removed; OHRP recommends prorating payment for time in the study.
What should I ask the study team about risks, placebo, visit schedule, and payment before enrolling?
Ask what procedures and risks are involved, whether assignment to placebo is possible, how long participation lasts, and how many visits or overnight stays are required. Confirm payment timing and withdrawal terms, travel reimbursement, additional costs, and what medical treatment or compensation is available if a research-related injury occurs.
Sources
- ClinicalTrials.gov — How to Search for Clinical Studies
- ClinicalTrials.gov — Retatrutide study NCT07232719
- ClinicalTrials.gov — Retatrutide study NCT07467447
- HHS Office for Human Research Protections — Informed Consent FAQs
- HHS Secretary’s Advisory Committee on Human Research Protections — Offers of Payment to Research Participants
Disclaimer: This article is for general information only and is not medical advice. It is not a substitute for diagnosis or treatment by a qualified healthcare professional. Always speak to your doctor before acting on anything you read here.



